EBITDA

Freedom Trail Capital joins Kapor Capital and the NBA, revealing a new investment model where authentic influence is the ultimate unfair advantage.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

Australian giant Cobram Estate Olives acquires #1 US brand California Olive Ranch, creating a new global leader in the extra virgin olive oil market.

Dubai hits its highest-ever rank in the Global Financial Centres Index, solidifying its MEASA dominance and fast-tracking its D33 vision to join the elite.

After a turbulent year, Tidewater Renewables projects a major profit surge in 2026, fueled by operational fixes and powerful government support programs.

An Oklahoma firm is a finalist at a top cardiology conference with a device that could make uncomfortable blood pressure cuffs a thing of the past.

Italy's top fashion retailer OVS launches its second Indian store in Mumbai, signaling a major push into the nation's competitive apparel market.

Autonomous driving firm Pony.ai announces a first-ever quarterly profit and a bold plan to deploy 3,000 robotaxis globally by the end of 2026.

The new platform centralizes historical trade records, aiming to streamline broker workflows amid rising market complexity and a surge in digital tool adoption.

China Mobile Hong Kong's premium club partners with Art Basel for a digital art debut, signaling a telco's bold move into the luxury cultural landscape.

Despite revenue growth, ICAPE Group posts a net loss after deciding to close two plants, signaling a pivot to a leaner model focused on innovation.

As big banks retreat, private lenders and small investors are revitalizing neighborhoods and adding homes to a market in desperate need of supply.

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

As homeowners face high interest rates, companies like Unison are turning home equity into a new, tradable asset class for institutional investors.

Ono Pharma's application for ripretinib could bring a vital new treatment to Japanese GIST patients who have exhausted all other options.

Strong product sales and innovation clash with a steep service decline in Europe, forcing Enerpac to restructure and adjust its outlook for 2026.

A parent's multi-year legal battle over financial mismanagement has ended in a landmark settlement, forcing major governance and transparency reforms.

The successful launch of rosacea treatment Emrosi™ generated $14.7M, driving Journey Medical's revenue to $61.9M and signaling a major strategic win.

In a critical exercise, Firefly Aerospace and Lockheed Martin proved satellites can be readied in hours, a key step in the U.S. plan for space defense.

Northland Power adds former Brookfield CFO Bahir Manios to its board, a strategic move to leverage elite infrastructure expertise for its global expansion.